The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype
出版年份 2013 全文链接
标题
The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype
作者
关键词
-
出版物
FASEB JOURNAL
Volume 27, Issue 7, Pages 2573-2583
出版商
FASEB
发表日期
2013-03-16
DOI
10.1096/fj.13-227728
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Resolvins: Anti-Inflammatory and Proresolving Mediators Derived from Omega-3 Polyunsaturated Fatty Acids
- (2012) Michael J. Zhang et al. Annual Review of Nutrition
- Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC–MS/MS
- (2012) Martin Giera et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators
- (2012) J. Dalli et al. BLOOD
- Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain
- (2012) Charles N. Serhan et al. FASEB JOURNAL
- Role of Basic Science in the Development of New Medicines: Examples from the Eicosanoid Field
- (2012) Bengt Samuelsson JOURNAL OF BIOLOGICAL CHEMISTRY
- Infection regulates pro-resolving mediators that lower antibiotic requirements
- (2012) Nan Chiang et al. NATURE
- New Lives Given by Cell Death: Macrophage Differentiation Following Their Encounter with Apoptotic Leukocytes during the Resolution of Inflammation
- (2012) Amiram Ariel et al. Frontiers in Immunology
- Transcriptomic analyses of murine resolution-phase macrophages
- (2011) M. J. Stables et al. BLOOD
- Resolvins and Protectins in Inflammation Resolution
- (2011) Charles N. Serhan et al. CHEMICAL REVIEWS
- Fatty acids and inflammation: The cutting edge between food and pharma
- (2011) Philip C. Calder EUROPEAN JOURNAL OF PHARMACOLOGY
- Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice
- (2011) Jason Hellmann et al. FASEB JOURNAL
- Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation
- (2011) Sungwhan F. Oh et al. JOURNAL OF CLINICAL INVESTIGATION
- Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype
- (2011) Esther Titos et al. JOURNAL OF IMMUNOLOGY
- n–3 Fatty Acids in Cardiovascular Disease
- (2011) Raffaele De Caterina NEW ENGLAND JOURNAL OF MEDICINE
- 14S,21R-dihydroxy-docosahexaenoic Acid Treatment Enhances Mesenchymal Stem Cell Amelioration of Renal Ischemia/Reperfusion Injury
- (2011) Haibin Tian et al. STEM CELLS AND DEVELOPMENT
- Monocyte trafficking in acute and chronic inflammation
- (2011) Molly A. Ingersoll et al. TRENDS IN IMMUNOLOGY
- 14S,21R-Dihydroxydocosahexaenoic Acid Remedies Impaired Healing and Mesenchymal Stem Cell Functions in Diabetic Wounds
- (2010) Haibin Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolic oxidation regulates embryonic stem cell differentiation
- (2010) Oscar Yanes et al. Nature Chemical Biology
- Novel 14,21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing
- (2009) Yan Lu et al. JOURNAL OF LIPID RESEARCH
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
- (2009) Matthew Spite et al. NATURE
- Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation
- (2008) Takao Shimizu Annual Review of Pharmacology and Toxicology
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
- (2008) Charles N. Serhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started